A detailed history of Altman Advisors, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Altman Advisors, Inc. holds 8,598 shares of ZTS stock, worth $1.54 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
8,598
Previous 8,284 3.79%
Holding current value
$1.54 Million
Previous $1.64 Million 11.07%
% of portfolio
0.71%
Previous 0.86%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$165.67 - $199.94 $52,020 - $62,781
314 Added 3.79%
8,598 $1.45 Million
Q4 2023

Feb 07, 2024

BUY
$151.44 - $200.09 $13,781 - $18,208
91 Added 1.11%
8,284 $1.64 Million
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $54,654 - $63,035
327 Added 4.16%
8,193 $1.43 Million
Q1 2023

May 09, 2023

BUY
$145.48 - $175.02 $16,875 - $20,302
116 Added 1.5%
7,866 $1.31 Million
Q4 2022

Feb 08, 2023

SELL
$131.14 - $157.47 $43,931 - $52,752
-335 Reduced 4.14%
7,750 $1.14 Million
Q3 2022

Nov 07, 2022

BUY
$148.29 - $182.55 $57,091 - $70,281
385 Added 5.0%
8,085 $1.2 Million
Q2 2022

Aug 08, 2022

BUY
$155.97 - $200.09 $1,091 - $1,400
7 Added 0.09%
7,700 $1.38 Million
Q1 2022

May 09, 2022

BUY
$181.39 - $234.03 $5,623 - $7,254
31 Added 0.4%
7,693 $1.45 Million
Q4 2021

Feb 08, 2022

BUY
$193.69 - $247.03 $3,486 - $4,446
18 Added 0.24%
7,662 $1.54 Million
Q3 2021

Nov 09, 2021

BUY
$189.29 - $209.69 $13,818 - $15,307
73 Added 0.96%
7,644 $1.65 Million
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $70,622 - $85,159
453 Added 6.36%
7,571 $1.51 Million
Q1 2021

May 14, 2021

SELL
$144.0 - $169.39 $1.01 Million - $1.18 Million
-6,993 Reduced 49.56%
7,118 $1.12 Million
Q4 2020

Feb 10, 2021

SELL
$157.07 - $174.35 $306,757 - $340,505
-1,953 Reduced 12.16%
14,111 $2.34 Million
Q3 2020

Nov 13, 2020

SELL
$137.1 - $165.37 $13,161 - $15,875
-96 Reduced 0.59%
16,064 $2.66 Million
Q2 2020

Aug 12, 2020

SELL
$111.92 - $142.53 $491,216 - $625,564
-4,389 Reduced 21.36%
16,160 $2.22 Million
Q1 2020

Apr 20, 2020

SELL
$92.66 - $144.94 $208,299 - $325,825
-2,248 Reduced 9.86%
20,549 $2.42 Million
Q4 2019

Jan 17, 2020

SELL
$116.25 - $133.25 $123,341 - $141,378
-1,061 Reduced 4.45%
22,797 $3.02 Million
Q3 2019

Oct 09, 2019

SELL
$112.57 - $128.43 $60,450 - $68,966
-537 Reduced 2.2%
23,858 $2.97 Million
Q2 2019

Jul 12, 2019

BUY
$97.98 - $114.28 $17,342 - $20,227
177 Added 0.73%
24,395 $2.77 Million
Q1 2019

Apr 12, 2019

SELL
$81.56 - $100.67 $88,981 - $109,830
-1,091 Reduced 4.31%
24,218 $2.44 Million
Q4 2018

Feb 07, 2019

BUY
$79.28 - $95.27 $1,427 - $1,714
18 Added 0.07%
25,309 $2.17 Million
Q3 2018

Nov 13, 2018

SELL
$83.5 - $93.23 $143,369 - $160,075
-1,717 Reduced 6.36%
25,291 $2.32 Million
Q2 2018

Aug 02, 2018

SELL
$79.9 - $89.2 $19,975 - $22,300
-250 Reduced 0.92%
27,008 $2.25 Million
Q1 2018

Apr 27, 2018

BUY
$71.51 - $84.69 $10,368 - $12,280
145 Added 0.53%
27,258 $2.28 Million
Q4 2017

Feb 15, 2018

BUY
$63.24 - $72.8 $1.71 Million - $1.97 Million
27,113
27,113 $1.95 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Altman Advisors, Inc. Portfolio

Follow Altman Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altman Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Altman Advisors, Inc. with notifications on news.